US regulator clears PTC’s medicine to treat a rare genetic metabolic diseaseÂ
HQ Team July 29, 2025: The US Food and Drug Administration cleared PTC Therapeutics’ sepiapterin for treating children and adults with a rare.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team July 29, 2025: The US Food and Drug Administration cleared PTC Therapeutics’ sepiapterin for treating children and adults with a rare.
HQ Team July 28, 2025: At least 24 children under the age of five died of malnutrition this month in the conflict-ridden Gaza.
HQ Team July 2, 2025: In less than two years, one child has been killed or maimed every 15 minutes in conflicts across.
HQ Team May 14, 2025: The US regulator is initiating action to remove concentrated ingestible fluoride prescription drug products for children from the.
HQ Team May 14, 2025: UN relief chief Tom Fletcher has told the Security Council that the ambassadors must finally act decisively “to.
HQ Team April 23, 2025: Displacement caused by an internal conflict between the government and armed militants, weather extremes, and funding cuts is.
A mystery illness sweeping over Congo has killed 53 people and infected 400 more, with an initial probe tracking the outbreak to three.
Saudi Arabia has reaffirmed a $500 million pledge to the WHO’s Global Polio Eradication Initiative to fight the disease plaguing vulnerable children, according.
Bharti Jayshankar January 11, 2024: Excessive screen time of children is a growing concern as many studies have correlated cognitive and language skills.
The US regulator has extended a review of an application by Organon & Co.’s atopic dermatitis (eczema) drug by three months with a.